Berg, G., Barchuk, M., Lobo, M
Close to one year on, Ive lost around 35 pounds (thats around 2.5 stone)
Tirzepatide (Mounjaro): A Dual-Action Breakthrough for Type 2 Diabetes and Weight Loss Abstract Tirzepatide, marketed as Mounjaro, is a groundbreaking dual GIP and GLP-1 receptor agonist approved for the treatment of type 2 diabetes
A balanced diet can improve how well these medications work
Ready to talk strategy
384:75565 Bhaskaran K, dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L (2018) Association of BMI with overall and cause-specific mortality: a population-based cohort study of 36 million adults in the UK